Aurora Cannabis (TSE:ACB) Hits New 52-Week Low – Time to Sell?

Aurora Cannabis Inc. (TSE:ACB) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.00 and last traded at C$7.11, with a volume of 115417 shares changing hands. The stock had previously closed at C$7.37.

Analyst Ratings Changes

Several analysts recently weighed in on the company. TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. ATB Capital lowered their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. Finally, Atb Cap Markets upgraded shares of Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th.

Aurora Cannabis Stock Down 4.6 %

The company has a market capitalization of C$384.60 million, a price-to-earnings ratio of -8.68 and a beta of 2.71. The company has a debt-to-equity ratio of 18.72, a current ratio of 3.42 and a quick ratio of 2.48. The firm’s fifty day moving average price is C$6.80 and its 200-day moving average price is C$7.15.

Insiders Place Their Bets

In other Aurora Cannabis news, Senior Officer Andre Jerome sold 13,390 shares of the business’s stock in a transaction that occurred on Wednesday, February 12th. The shares were sold at an average price of C$9.30, for a total transaction of C$124,524.32.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.